Articles and Reports

This interview analysis is sponsored by OneTrust and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Searce and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Generative AI (GenAI) is rapidly transforming customer service, helping enterprises cut costs, boost efficiency, and meet regulatory requirements.

As AI adoption grows, so do the associated risks, including errors, biases, and unexpected outcomes. However, as AI becomes more integral to core business operations, managing operational and financial risks becomes paramount. One way to offset that risk is to ensure AI models. However, that can be difficult to achieve as the process is complex. 

This interview analysis is sponsored by OneTrust and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Hyperscience and was written, edited, and published in alignment with our Emerj-sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Medable and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.Although there is seemingly a constant stream of impressive headlines touting new drug treatments or potential cancer cures, medical breakthroughs occur at a slow pace. It can take upwards of 10 years from the time a medical breakthrough is discovered until it is eventually available in the market.Clinical trials are necessary to test the safety and effectiveness of new treatments. When clinical trials fail before they even start, medical breakthroughs are obviously delayed. Fortunately, the emergence of AI has the potential to change that situation. 

Merck, a global leader in healthcare and pharmaceuticals, focuses on developing innovative medicines, vaccines, and animal health products to improve lives worldwide.